Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer.
Pourgholami MH, Szwajcer M, Chin M, Liauw W, Seef J, Galettis P, Morris DL, Links M.
Pourgholami MH, et al.
Cancer Chemother Pharmacol. 2010 Feb;65(3):597-605. doi: 10.1007/s00280-009-1157-8.
Cancer Chemother Pharmacol. 2010.
PMID: 19904538
Clinical Trial.
Albendazole was given orally on a day 1-14 of a 3 weekly cycle, starting at 400 mg BD with dose escalation until 1,200 mg BD. Serial blood samples were collected up to 96 h and also on day 8 of cycles 1 and 4. RESULTS: The maximum tolerated dose was 2,400 mg per day (1,200 …
Albendazole was given orally on a day 1-14 of a 3 weekly cycle, starting at 400 mg BD with dose escalation until 1,200 mg BD. Serial blood s …